Bob Dagher
Director Técnico/Científico/I+D en BRAINSTORM CELL THERAPEUTICS INC. .
Fortuna: 134 596 $ al 30/04/2024
Perfil
Dr. Bob Dagher, MD, is a Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. Dr. Dagher was previously employed as a Chief Medical Officer by Enveric Biosciences, Inc., a Chief Medical Officer-WCG MedAvante-ProPhase by Cadent Therapeutics, Inc., a Senior Medical Director by Covance, Inc., and a Chief Medical Officer by MedAvante-ProPhase, Inc. He received his undergraduate degree from Université de Bordeaux and an undergraduate degree from Faculté De Médecine Necker Enfants Malades Université.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/04/2024 | 253 000 ( 0.37% ) | 134 596 $ | 30/04/2024 |
Cargos activos de Bob Dagher
| Empresas | Cargo | Inicio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director Técnico/Científico/I+D | 16/04/2024 |
Antiguos cargos conocidos de Bob Dagher.
| Empresas | Cargo | Fin |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/01/2023 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2021 |
| COVANCE INC. | Director Técnico/Científico/I+D | 01/01/2019 |
| MedAvante-ProPhase, Inc. | Director Técnico/Científico/I+D | - |
Formación de Bob Dagher.
| Université de Bordeaux | Undergraduate Degree |
| Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
| MedAvante-ProPhase, Inc. |
- Bolsa de valores
- Insiders
- Bob Dagher